Nanopharmaceuticals Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Nanopharmaceuticals in global, including the following market information:
Global Nanopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nanopharmaceuticals Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Nanopharmaceuticals companies in 2020 (%)
The global Nanopharmaceuticals market was valued at 28190 million in 2020 and is projected to reach US$ 45070 million by 2027, at a CAGR of 12.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, By Type, 2020 (%)
Global Nanopharmaceuticals Market Segment Percentages, By Application, 2020 (%)
Global Nanopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceuticals revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nanopharmaceuticals revenues share in global market, 2020 (%)
Key companies Nanopharmaceuticals sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Nanopharmaceuticals sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Nanopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nanopharmaceuticals Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Nanopharmaceuticals companies in 2020 (%)
The global Nanopharmaceuticals market was valued at 28190 million in 2020 and is projected to reach US$ 45070 million by 2027, at a CAGR of 12.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, By Type, 2020 (%)
- Liposomes
- Polymeric Micelles
- Solid Lipid Nanoparticles
- Microemulsion and Nnanoemulsion
- Nanosuspension
Global Nanopharmaceuticals Market Segment Percentages, By Application, 2020 (%)
- Cancer and Tumor
- Autoimmune Disorders
- Inflammation
- Others
Global Nanopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceuticals revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nanopharmaceuticals revenues share in global market, 2020 (%)
Key companies Nanopharmaceuticals sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Nanopharmaceuticals sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Pfizer
- Novartis
- Abbott
- GlaxoSmithKline
- Roche
- Sanofi
- Eli Lilly
- Astrazeneca
- Johnson & Johnson
- Celgene
- Novavax
- Stryker
- Gilead Sciences
- OSI Pharmaceuticals
- Kadmon Pharmaceuticals
- Samyang Biopharm
- Mitsubishi Pharma
- Kaken Pharmaceutical
- Selecta Biosciences
- Par Pharmaceutical
- Cerulean Pharma
- Navidea Biopharmaceuticals
- Lummy
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Nanopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NANOPHARMACEUTICALS OVERALL MARKET SIZE
2.1 Global Nanopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Nanopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nanopharmaceuticals Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Nanopharmaceuticals Players in Global Market
3.2 Top Global Nanopharmaceuticals Companies Ranked by Revenue
3.3 Global Nanopharmaceuticals Revenue by Companies
3.4 Global Nanopharmaceuticals Sales by Companies
3.5 Global Nanopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nanopharmaceuticals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nanopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nanopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nanopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nanopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Liposomes
4.1.3 Polymeric Micelles
4.1.4 Solid Lipid Nanoparticles
4.1.5 Microemulsion and Nnanoemulsion
4.1.6 Nanosuspension
4.2 By Type - Global Nanopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nanopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global Nanopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - Global Nanopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nanopharmaceuticals Sales, 2016-2021
4.3.2 By Type - Global Nanopharmaceuticals Sales, 2022-2027
4.3.3 By Type - Global Nanopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nanopharmaceuticals Market Size, 2021 & 2027
5.1.2 Cancer and Tumor
5.1.3 Autoimmune Disorders
5.1.4 Inflammation
5.1.5 Others
5.2 By Application - Global Nanopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nanopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global Nanopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - Global Nanopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nanopharmaceuticals Sales, 2016-2021
5.3.2 By Application - Global Nanopharmaceuticals Sales, 2022-2027
5.3.3 By Application - Global Nanopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Nanopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Nanopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nanopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global Nanopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
6.3 By Region - Global Nanopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nanopharmaceuticals Sales, 2016-2021
6.3.2 By Region - Global Nanopharmaceuticals Sales, 2022-2027
6.3.3 By Region - Global Nanopharmaceuticals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nanopharmaceuticals Revenue, 2016-2027
6.4.2 By Country - North America Nanopharmaceuticals Sales, 2016-2027
6.4.3 US Nanopharmaceuticals Market Size, 2016-2027
6.4.4 Canada Nanopharmaceuticals Market Size, 2016-2027
6.4.5 Mexico Nanopharmaceuticals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nanopharmaceuticals Revenue, 2016-2027
6.5.2 By Country - Europe Nanopharmaceuticals Sales, 2016-2027
6.5.3 Germany Nanopharmaceuticals Market Size, 2016-2027
6.5.4 France Nanopharmaceuticals Market Size, 2016-2027
6.5.5 U.K. Nanopharmaceuticals Market Size, 2016-2027
6.5.6 Italy Nanopharmaceuticals Market Size, 2016-2027
6.5.7 Russia Nanopharmaceuticals Market Size, 2016-2027
6.5.8 Nordic Countries Nanopharmaceuticals Market Size, 2016-2027
6.5.9 Benelux Nanopharmaceuticals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nanopharmaceuticals Revenue, 2016-2027
6.6.2 By Region - Asia Nanopharmaceuticals Sales, 2016-2027
6.6.3 China Nanopharmaceuticals Market Size, 2016-2027
6.6.4 Japan Nanopharmaceuticals Market Size, 2016-2027
6.6.5 South Korea Nanopharmaceuticals Market Size, 2016-2027
6.6.6 Southeast Asia Nanopharmaceuticals Market Size, 2016-2027
6.6.7 India Nanopharmaceuticals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nanopharmaceuticals Revenue, 2016-2027
6.7.2 By Country - South America Nanopharmaceuticals Sales, 2016-2027
6.7.3 Brazil Nanopharmaceuticals Market Size, 2016-2027
6.7.4 Argentina Nanopharmaceuticals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nanopharmaceuticals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nanopharmaceuticals Sales, 2016-2027
6.8.3 Turkey Nanopharmaceuticals Market Size, 2016-2027
6.8.4 Israel Nanopharmaceuticals Market Size, 2016-2027
6.8.5 Saudi Arabia Nanopharmaceuticals Market Size, 2016-2027
6.8.6 UAE Nanopharmaceuticals Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Nanopharmaceuticals Major Product Offerings
7.1.4 Merck Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nanopharmaceuticals Major Product Offerings
7.2.4 Pfizer Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Nanopharmaceuticals Major Product Offerings
7.3.4 Novartis Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Nanopharmaceuticals Major Product Offerings
7.4.4 Abbott Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.4.5 Abbott Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Nanopharmaceuticals Major Product Offerings
7.5.4 GlaxoSmithKline Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Nanopharmaceuticals Major Product Offerings
7.6.4 Roche Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.6.5 Roche Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanopharmaceuticals Major Product Offerings
7.4.4 Sanofi Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nanopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Nanopharmaceuticals Major Product Offerings
7.9.4 Astrazeneca Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Nanopharmaceuticals Major Product Offerings
7.10.4 Johnson & Johnson Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.10.5 Johnson & Johnson Key News
7.11 Celgene
7.11.1 Celgene Corporate Summary
7.11.2 Celgene Nanopharmaceuticals Business Overview
7.11.3 Celgene Nanopharmaceuticals Major Product Offerings
7.11.4 Celgene Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.11.5 Celgene Key News
7.12 Novavax
7.12.1 Novavax Corporate Summary
7.12.2 Novavax Nanopharmaceuticals Business Overview
7.12.3 Novavax Nanopharmaceuticals Major Product Offerings
7.12.4 Novavax Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.12.5 Novavax Key News
7.13 Stryker
7.13.1 Stryker Corporate Summary
7.13.2 Stryker Nanopharmaceuticals Business Overview
7.13.3 Stryker Nanopharmaceuticals Major Product Offerings
7.13.4 Stryker Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.13.5 Stryker Key News
7.14 Gilead Sciences
7.14.1 Gilead Sciences Corporate Summary
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Nanopharmaceuticals Major Product Offerings
7.14.4 Gilead Sciences Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.14.5 Gilead Sciences Key News
7.15 OSI Pharmaceuticals
7.15.1 OSI Pharmaceuticals Corporate Summary
7.15.2 OSI Pharmaceuticals Business Overview
7.15.3 OSI Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.15.4 OSI Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.15.5 OSI Pharmaceuticals Key News
7.16 Kadmon Pharmaceuticals
7.16.1 Kadmon Pharmaceuticals Corporate Summary
7.16.2 Kadmon Pharmaceuticals Business Overview
7.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.16.5 Kadmon Pharmaceuticals Key News
7.17 Samyang Biopharm
7.17.1 Samyang Biopharm Corporate Summary
7.17.2 Samyang Biopharm Business Overview
7.17.3 Samyang Biopharm Nanopharmaceuticals Major Product Offerings
7.17.4 Samyang Biopharm Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.17.5 Samyang Biopharm Key News
7.18 Mitsubishi Pharma
7.18.1 Mitsubishi Pharma Corporate Summary
7.18.2 Mitsubishi Pharma Business Overview
7.18.3 Mitsubishi Pharma Nanopharmaceuticals Major Product Offerings
7.18.4 Mitsubishi Pharma Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.18.5 Mitsubishi Pharma Key News
7.19 Kaken Pharmaceutical
7.19.1 Kaken Pharmaceutical Corporate Summary
7.19.2 Kaken Pharmaceutical Business Overview
7.19.3 Kaken Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.19.4 Kaken Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.19.5 Kaken Pharmaceutical Key News
7.20 Selecta Biosciences
7.20.1 Selecta Biosciences Corporate Summary
7.20.2 Selecta Biosciences Business Overview
7.20.3 Selecta Biosciences Nanopharmaceuticals Major Product Offerings
7.20.4 Selecta Biosciences Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.20.5 Selecta Biosciences Key News
7.21 Par Pharmaceutical
7.21.1 Par Pharmaceutical Corporate Summary
7.21.2 Par Pharmaceutical Business Overview
7.21.3 Par Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.21.4 Par Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.21.5 Par Pharmaceutical Key News
7.22 Cerulean Pharma
7.22.1 Cerulean Pharma Corporate Summary
7.22.2 Cerulean Pharma Business Overview
7.22.3 Cerulean Pharma Nanopharmaceuticals Major Product Offerings
7.22.4 Cerulean Pharma Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.22.5 Cerulean Pharma Key News
7.23 Navidea Biopharmaceuticals
7.23.1 Navidea Biopharmaceuticals Corporate Summary
7.23.2 Navidea Biopharmaceuticals Business Overview
7.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Major Product Offerings
7.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.23.5 Navidea Biopharmaceuticals Key News
7.24 Lummy
7.24.1 Lummy Corporate Summary
7.24.2 Lummy Business Overview
7.24.3 Lummy Nanopharmaceuticals Major Product Offerings
7.24.4 Lummy Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.24.5 Lummy Key News
8 GLOBAL NANOPHARMACEUTICALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nanopharmaceuticals Production Capacity, 2016-2027
8.2 Nanopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nanopharmaceuticals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NANOPHARMACEUTICALS SUPPLY CHAIN ANALYSIS
10.1 Nanopharmaceuticals Industry Value Chain
10.2 Nanopharmaceuticals Upstream Market
10.3 Nanopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nanopharmaceuticals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Nanopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NANOPHARMACEUTICALS OVERALL MARKET SIZE
2.1 Global Nanopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Nanopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nanopharmaceuticals Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Nanopharmaceuticals Players in Global Market
3.2 Top Global Nanopharmaceuticals Companies Ranked by Revenue
3.3 Global Nanopharmaceuticals Revenue by Companies
3.4 Global Nanopharmaceuticals Sales by Companies
3.5 Global Nanopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nanopharmaceuticals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nanopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nanopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nanopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nanopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Liposomes
4.1.3 Polymeric Micelles
4.1.4 Solid Lipid Nanoparticles
4.1.5 Microemulsion and Nnanoemulsion
4.1.6 Nanosuspension
4.2 By Type - Global Nanopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nanopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global Nanopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - Global Nanopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nanopharmaceuticals Sales, 2016-2021
4.3.2 By Type - Global Nanopharmaceuticals Sales, 2022-2027
4.3.3 By Type - Global Nanopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nanopharmaceuticals Market Size, 2021 & 2027
5.1.2 Cancer and Tumor
5.1.3 Autoimmune Disorders
5.1.4 Inflammation
5.1.5 Others
5.2 By Application - Global Nanopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nanopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global Nanopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - Global Nanopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nanopharmaceuticals Sales, 2016-2021
5.3.2 By Application - Global Nanopharmaceuticals Sales, 2022-2027
5.3.3 By Application - Global Nanopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - Global Nanopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Nanopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Nanopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nanopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global Nanopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
6.3 By Region - Global Nanopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nanopharmaceuticals Sales, 2016-2021
6.3.2 By Region - Global Nanopharmaceuticals Sales, 2022-2027
6.3.3 By Region - Global Nanopharmaceuticals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nanopharmaceuticals Revenue, 2016-2027
6.4.2 By Country - North America Nanopharmaceuticals Sales, 2016-2027
6.4.3 US Nanopharmaceuticals Market Size, 2016-2027
6.4.4 Canada Nanopharmaceuticals Market Size, 2016-2027
6.4.5 Mexico Nanopharmaceuticals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nanopharmaceuticals Revenue, 2016-2027
6.5.2 By Country - Europe Nanopharmaceuticals Sales, 2016-2027
6.5.3 Germany Nanopharmaceuticals Market Size, 2016-2027
6.5.4 France Nanopharmaceuticals Market Size, 2016-2027
6.5.5 U.K. Nanopharmaceuticals Market Size, 2016-2027
6.5.6 Italy Nanopharmaceuticals Market Size, 2016-2027
6.5.7 Russia Nanopharmaceuticals Market Size, 2016-2027
6.5.8 Nordic Countries Nanopharmaceuticals Market Size, 2016-2027
6.5.9 Benelux Nanopharmaceuticals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nanopharmaceuticals Revenue, 2016-2027
6.6.2 By Region - Asia Nanopharmaceuticals Sales, 2016-2027
6.6.3 China Nanopharmaceuticals Market Size, 2016-2027
6.6.4 Japan Nanopharmaceuticals Market Size, 2016-2027
6.6.5 South Korea Nanopharmaceuticals Market Size, 2016-2027
6.6.6 Southeast Asia Nanopharmaceuticals Market Size, 2016-2027
6.6.7 India Nanopharmaceuticals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nanopharmaceuticals Revenue, 2016-2027
6.7.2 By Country - South America Nanopharmaceuticals Sales, 2016-2027
6.7.3 Brazil Nanopharmaceuticals Market Size, 2016-2027
6.7.4 Argentina Nanopharmaceuticals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nanopharmaceuticals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nanopharmaceuticals Sales, 2016-2027
6.8.3 Turkey Nanopharmaceuticals Market Size, 2016-2027
6.8.4 Israel Nanopharmaceuticals Market Size, 2016-2027
6.8.5 Saudi Arabia Nanopharmaceuticals Market Size, 2016-2027
6.8.6 UAE Nanopharmaceuticals Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Nanopharmaceuticals Major Product Offerings
7.1.4 Merck Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nanopharmaceuticals Major Product Offerings
7.2.4 Pfizer Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Nanopharmaceuticals Major Product Offerings
7.3.4 Novartis Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Nanopharmaceuticals Major Product Offerings
7.4.4 Abbott Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.4.5 Abbott Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Nanopharmaceuticals Major Product Offerings
7.5.4 GlaxoSmithKline Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Nanopharmaceuticals Major Product Offerings
7.6.4 Roche Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.6.5 Roche Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanopharmaceuticals Major Product Offerings
7.4.4 Sanofi Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Nanopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.8.5 Eli Lilly Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Nanopharmaceuticals Major Product Offerings
7.9.4 Astrazeneca Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Nanopharmaceuticals Major Product Offerings
7.10.4 Johnson & Johnson Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.10.5 Johnson & Johnson Key News
7.11 Celgene
7.11.1 Celgene Corporate Summary
7.11.2 Celgene Nanopharmaceuticals Business Overview
7.11.3 Celgene Nanopharmaceuticals Major Product Offerings
7.11.4 Celgene Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.11.5 Celgene Key News
7.12 Novavax
7.12.1 Novavax Corporate Summary
7.12.2 Novavax Nanopharmaceuticals Business Overview
7.12.3 Novavax Nanopharmaceuticals Major Product Offerings
7.12.4 Novavax Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.12.5 Novavax Key News
7.13 Stryker
7.13.1 Stryker Corporate Summary
7.13.2 Stryker Nanopharmaceuticals Business Overview
7.13.3 Stryker Nanopharmaceuticals Major Product Offerings
7.13.4 Stryker Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.13.5 Stryker Key News
7.14 Gilead Sciences
7.14.1 Gilead Sciences Corporate Summary
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Nanopharmaceuticals Major Product Offerings
7.14.4 Gilead Sciences Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.14.5 Gilead Sciences Key News
7.15 OSI Pharmaceuticals
7.15.1 OSI Pharmaceuticals Corporate Summary
7.15.2 OSI Pharmaceuticals Business Overview
7.15.3 OSI Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.15.4 OSI Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.15.5 OSI Pharmaceuticals Key News
7.16 Kadmon Pharmaceuticals
7.16.1 Kadmon Pharmaceuticals Corporate Summary
7.16.2 Kadmon Pharmaceuticals Business Overview
7.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Major Product Offerings
7.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.16.5 Kadmon Pharmaceuticals Key News
7.17 Samyang Biopharm
7.17.1 Samyang Biopharm Corporate Summary
7.17.2 Samyang Biopharm Business Overview
7.17.3 Samyang Biopharm Nanopharmaceuticals Major Product Offerings
7.17.4 Samyang Biopharm Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.17.5 Samyang Biopharm Key News
7.18 Mitsubishi Pharma
7.18.1 Mitsubishi Pharma Corporate Summary
7.18.2 Mitsubishi Pharma Business Overview
7.18.3 Mitsubishi Pharma Nanopharmaceuticals Major Product Offerings
7.18.4 Mitsubishi Pharma Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.18.5 Mitsubishi Pharma Key News
7.19 Kaken Pharmaceutical
7.19.1 Kaken Pharmaceutical Corporate Summary
7.19.2 Kaken Pharmaceutical Business Overview
7.19.3 Kaken Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.19.4 Kaken Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.19.5 Kaken Pharmaceutical Key News
7.20 Selecta Biosciences
7.20.1 Selecta Biosciences Corporate Summary
7.20.2 Selecta Biosciences Business Overview
7.20.3 Selecta Biosciences Nanopharmaceuticals Major Product Offerings
7.20.4 Selecta Biosciences Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.20.5 Selecta Biosciences Key News
7.21 Par Pharmaceutical
7.21.1 Par Pharmaceutical Corporate Summary
7.21.2 Par Pharmaceutical Business Overview
7.21.3 Par Pharmaceutical Nanopharmaceuticals Major Product Offerings
7.21.4 Par Pharmaceutical Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.21.5 Par Pharmaceutical Key News
7.22 Cerulean Pharma
7.22.1 Cerulean Pharma Corporate Summary
7.22.2 Cerulean Pharma Business Overview
7.22.3 Cerulean Pharma Nanopharmaceuticals Major Product Offerings
7.22.4 Cerulean Pharma Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.22.5 Cerulean Pharma Key News
7.23 Navidea Biopharmaceuticals
7.23.1 Navidea Biopharmaceuticals Corporate Summary
7.23.2 Navidea Biopharmaceuticals Business Overview
7.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Major Product Offerings
7.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.23.5 Navidea Biopharmaceuticals Key News
7.24 Lummy
7.24.1 Lummy Corporate Summary
7.24.2 Lummy Business Overview
7.24.3 Lummy Nanopharmaceuticals Major Product Offerings
7.24.4 Lummy Nanopharmaceuticals Sales and Revenue in Global (2016-2021)
7.24.5 Lummy Key News
8 GLOBAL NANOPHARMACEUTICALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nanopharmaceuticals Production Capacity, 2016-2027
8.2 Nanopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nanopharmaceuticals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NANOPHARMACEUTICALS SUPPLY CHAIN ANALYSIS
10.1 Nanopharmaceuticals Industry Value Chain
10.2 Nanopharmaceuticals Upstream Market
10.3 Nanopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nanopharmaceuticals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Nanopharmaceuticals in Global Market
Table 2. Top Nanopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nanopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nanopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. Global Nanopharmaceuticals Sales by Companies, (K MT), 2016-2021
Table 6. Global Nanopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nanopharmaceuticals Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Nanopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 15. By Type - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 16. By Application – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 20. By Application - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 21. By Region – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 25. By Region - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 26. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 29. By Country - North America Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 30. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 33. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 34. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 37. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 38. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 41. By Country - South America Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 46. Merck Corporate Summary
Table 47. Merck Nanopharmaceuticals Product Offerings
Table 48. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Nanopharmaceuticals Product Offerings
Table 51. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Novartis Corporate Summary
Table 53. Novartis Nanopharmaceuticals Product Offerings
Table 54. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Abbott Corporate Summary
Table 56. Abbott Nanopharmaceuticals Product Offerings
Table 57. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Nanopharmaceuticals Product Offerings
Table 60. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Roche Corporate Summary
Table 62. Roche Nanopharmaceuticals Product Offerings
Table 63. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Nanopharmaceuticals Product Offerings
Table 66. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Nanopharmaceuticals Product Offerings
Table 69. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Astrazeneca Corporate Summary
Table 71. Astrazeneca Nanopharmaceuticals Product Offerings
Table 72. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Johnson & Johnson Corporate Summary
Table 74. Johnson & Johnson Nanopharmaceuticals Product Offerings
Table 75. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Celgene Corporate Summary
Table 77. Celgene Nanopharmaceuticals Product Offerings
Table 78. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Novavax Corporate Summary
Table 80. Novavax Nanopharmaceuticals Product Offerings
Table 81. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Stryker Corporate Summary
Table 83. Stryker Nanopharmaceuticals Product Offerings
Table 84. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 85. Gilead Sciences Corporate Summary
Table 86. Gilead Sciences Nanopharmaceuticals Product Offerings
Table 87. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 88. OSI Pharmaceuticals Corporate Summary
Table 89. OSI Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 90. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 91. Kadmon Pharmaceuticals Corporate Summary
Table 92. Kadmon Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 93. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 94. Samyang Biopharm Corporate Summary
Table 95. Samyang Biopharm Nanopharmaceuticals Product Offerings
Table 96. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 97. Mitsubishi Pharma Corporate Summary
Table 98. Mitsubishi Pharma Nanopharmaceuticals Product Offerings
Table 99. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 100. Kaken Pharmaceutical Corporate Summary
Table 101. Kaken Pharmaceutical Nanopharmaceuticals Product Offerings
Table 102. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 103. Selecta Biosciences Corporate Summary
Table 104. Selecta Biosciences Nanopharmaceuticals Product Offerings
Table 105. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 106. Par Pharmaceutical Corporate Summary
Table 107. Par Pharmaceutical Nanopharmaceuticals Product Offerings
Table 108. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 109. Cerulean Pharma Corporate Summary
Table 110. Cerulean Pharma Nanopharmaceuticals Product Offerings
Table 111. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 112. Navidea Biopharmaceuticals Corporate Summary
Table 113. Navidea Biopharmaceuticals Nanopharmaceuticals Product Offerings
Table 114. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 115. Lummy Corporate Summary
Table 116. Lummy Nanopharmaceuticals Product Offerings
Table 117. Lummy Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 118. Nanopharmaceuticals Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 119. Global Nanopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 120. Global Nanopharmaceuticals Production by Region, 2016-2021 (K MT)
Table 121. Global Nanopharmaceuticals Production by Region, 2022-2027 (K MT)
Table 122. Nanopharmaceuticals Market Opportunities & Trends in Global Market
Table 123. Nanopharmaceuticals Market Drivers in Global Market
Table 124. Nanopharmaceuticals Market Restraints in Global Market
Table 125. Nanopharmaceuticals Raw Materials
Table 126. Nanopharmaceuticals Raw Materials Suppliers in Global Market
Table 127. Typical Nanopharmaceuticals Downstream
Table 128. Nanopharmaceuticals Downstream Clients in Global Market
Table 129. Nanopharmaceuticals Distributors and Sales Agents in Global Market
Table 1. Key Players of Nanopharmaceuticals in Global Market
Table 2. Top Nanopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nanopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nanopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. Global Nanopharmaceuticals Sales by Companies, (K MT), 2016-2021
Table 6. Global Nanopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nanopharmaceuticals Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Nanopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 15. By Type - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 16. By Application – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 20. By Application - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 21. By Region – Global Nanopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Nanopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Nanopharmaceuticals Sales (K MT), 2016-2021
Table 25. By Region - Global Nanopharmaceuticals Sales (K MT), 2022-2027
Table 26. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 29. By Country - North America Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 30. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 33. By Country - Europe Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 34. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 37. By Region - Asia Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 38. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 41. By Country - South America Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Nanopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Nanopharmaceuticals Sales, (K MT), 2022-2027
Table 46. Merck Corporate Summary
Table 47. Merck Nanopharmaceuticals Product Offerings
Table 48. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Nanopharmaceuticals Product Offerings
Table 51. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Novartis Corporate Summary
Table 53. Novartis Nanopharmaceuticals Product Offerings
Table 54. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Abbott Corporate Summary
Table 56. Abbott Nanopharmaceuticals Product Offerings
Table 57. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Nanopharmaceuticals Product Offerings
Table 60. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Roche Corporate Summary
Table 62. Roche Nanopharmaceuticals Product Offerings
Table 63. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Nanopharmaceuticals Product Offerings
Table 66. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Eli Lilly Corporate Summary
Table 68. Eli Lilly Nanopharmaceuticals Product Offerings
Table 69. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Astrazeneca Corporate Summary
Table 71. Astrazeneca Nanopharmaceuticals Product Offerings
Table 72. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Johnson & Johnson Corporate Summary
Table 74. Johnson & Johnson Nanopharmaceuticals Product Offerings
Table 75. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Celgene Corporate Summary
Table 77. Celgene Nanopharmaceuticals Product Offerings
Table 78. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Novavax Corporate Summary
Table 80. Novavax Nanopharmaceuticals Product Offerings
Table 81. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Stryker Corporate Summary
Table 83. Stryker Nanopharmaceuticals Product Offerings
Table 84. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 85. Gilead Sciences Corporate Summary
Table 86. Gilead Sciences Nanopharmaceuticals Product Offerings
Table 87. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 88. OSI Pharmaceuticals Corporate Summary
Table 89. OSI Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 90. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 91. Kadmon Pharmaceuticals Corporate Summary
Table 92. Kadmon Pharmaceuticals Nanopharmaceuticals Product Offerings
Table 93. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 94. Samyang Biopharm Corporate Summary
Table 95. Samyang Biopharm Nanopharmaceuticals Product Offerings
Table 96. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 97. Mitsubishi Pharma Corporate Summary
Table 98. Mitsubishi Pharma Nanopharmaceuticals Product Offerings
Table 99. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 100. Kaken Pharmaceutical Corporate Summary
Table 101. Kaken Pharmaceutical Nanopharmaceuticals Product Offerings
Table 102. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 103. Selecta Biosciences Corporate Summary
Table 104. Selecta Biosciences Nanopharmaceuticals Product Offerings
Table 105. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 106. Par Pharmaceutical Corporate Summary
Table 107. Par Pharmaceutical Nanopharmaceuticals Product Offerings
Table 108. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 109. Cerulean Pharma Corporate Summary
Table 110. Cerulean Pharma Nanopharmaceuticals Product Offerings
Table 111. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 112. Navidea Biopharmaceuticals Corporate Summary
Table 113. Navidea Biopharmaceuticals Nanopharmaceuticals Product Offerings
Table 114. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 115. Lummy Corporate Summary
Table 116. Lummy Nanopharmaceuticals Product Offerings
Table 117. Lummy Nanopharmaceuticals Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 118. Nanopharmaceuticals Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 119. Global Nanopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 120. Global Nanopharmaceuticals Production by Region, 2016-2021 (K MT)
Table 121. Global Nanopharmaceuticals Production by Region, 2022-2027 (K MT)
Table 122. Nanopharmaceuticals Market Opportunities & Trends in Global Market
Table 123. Nanopharmaceuticals Market Drivers in Global Market
Table 124. Nanopharmaceuticals Market Restraints in Global Market
Table 125. Nanopharmaceuticals Raw Materials
Table 126. Nanopharmaceuticals Raw Materials Suppliers in Global Market
Table 127. Typical Nanopharmaceuticals Downstream
Table 128. Nanopharmaceuticals Downstream Clients in Global Market
Table 129. Nanopharmaceuticals Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Nanopharmaceuticals Segment by Type
Figure 2. Nanopharmaceuticals Segment by Application
Figure 3. Global Nanopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nanopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nanopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. Nanopharmaceuticals Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Nanopharmaceuticals Revenue in 2020
Figure 9. By Type - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 10. By Type - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Type - Global Nanopharmaceuticals Price (USD/MT), 2016-2027
Figure 12. By Application - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 13. By Application - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 14. By Application - Global Nanopharmaceuticals Price (USD/MT), 2016-2027
Figure 15. By Region - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 16. By Region - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 17. By Country - North America Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 18. By Country - North America Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 19. US Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 24. Germany Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. France Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 33. China Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. India Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 39. By Country - South America Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 40. Brazil Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 44. Turkey Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 48. Global Nanopharmaceuticals Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Nanopharmaceuticals by Region, 2020 VS 2027
Figure 50. Nanopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Nanopharmaceuticals Segment by Type
Figure 2. Nanopharmaceuticals Segment by Application
Figure 3. Global Nanopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nanopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nanopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. Nanopharmaceuticals Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Nanopharmaceuticals Revenue in 2020
Figure 9. By Type - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 10. By Type - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Type - Global Nanopharmaceuticals Price (USD/MT), 2016-2027
Figure 12. By Application - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 13. By Application - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 14. By Application - Global Nanopharmaceuticals Price (USD/MT), 2016-2027
Figure 15. By Region - Global Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 16. By Region - Global Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 17. By Country - North America Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 18. By Country - North America Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 19. US Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 24. Germany Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. France Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 33. China Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. India Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 39. By Country - South America Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 40. Brazil Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Nanopharmaceuticals Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Nanopharmaceuticals Sales Market Share, 2016-2027
Figure 44. Turkey Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Nanopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 48. Global Nanopharmaceuticals Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Nanopharmaceuticals by Region, 2020 VS 2027
Figure 50. Nanopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
